Weighted Average Number of Shares Outstanding, Basic of ABVC BIOPHARMA, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ABVC BIOPHARMA, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2010 to Q3 2025.
  • ABVC BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 23.3M shares, a 87.5% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 11.7M shares, a 169% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.34M shares, a 36.9% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.17M shares, a 87.4% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 23.3M +10.9M +87.5% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 17.4M +6.07M +53.6% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 15M +5.23M +53.7% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 11.7M +7.34M +169% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 12.4M +8.35M +206% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025
Q2 2024 11.3M +8.01M +242% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 9.74M +6.43M +194% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 4.34M +1.17M +36.9% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 4.06M +797K +24.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 3.31M +178K +5.69% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 3.31M -26.4M -88.9% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 3.17M -21.9M -87.4% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 3.26M -23.6M -87.9% 01 Jul 2022 30 Sep 2022 10-Q 15 Nov 2023
Q2 2022 3.13M -21.3M -87.2% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 29.7M +5.26M +21.6% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 25.1M 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 26.9M +7.39M +37.9% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 24.4M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 24.4M 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q3 2020 19.5M 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2019 17.4M +5.81M +50.1% 01 Apr 2019 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 15M +3.37M +29% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2019
Q4 2018 214M +137K +0.06% 01 Oct 2018 31 Dec 2018 10-K 15 Apr 2019
Q3 2018 214M +180K +0.08% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 11.6M -202M -94.6% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 11.6M -200M -94.5% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019
Q4 2017 214M +2.93M +1.39% 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018
Q3 2017 214M 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 214M 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018
Q1 2017 212M 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 211M +46.9M +28.6% 01 Oct 2016 31 Dec 2016 10-Q/A 19 Mar 2018
Q4 2015 164M +109M +200% 01 Oct 2015 31 Dec 2015 10-Q/A 19 Mar 2018
Q3 2015 161M 21 Jul 2015 30 Sep 2015 10-K 22 Feb 2017
Q4 2014 54.6M 01 Oct 2014 31 Dec 2014 10-Q 23 Feb 2016
Q2 2012 28.9M +18.3M +171% 01 Apr 2012 30 Jun 2012 10-Q/A 20 Aug 2012
Q1 2012 16.3M +6.12M +60% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2012
Q4 2011 16.1M +9.22M +133% 01 Oct 2011 31 Dec 2011 10-Q 21 Feb 2012
Q3 2011 9.74M 01 Jul 2011 30 Sep 2011 10-K/A 28 Dec 2011
Q2 2011 10.7M +4.08M +61.9% 01 Apr 2011 30 Jun 2011 10-Q/A 20 Aug 2012
Q1 2011 10.2M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q4 2010 6.91M 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012
Q2 2010 6.58M 01 Apr 2010 30 Jun 2010 10-Q/A 08 Sep 2011

ABVC BIOPHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 11.7M +7.34M +169% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 4.34M +1.17M +36.9% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 3.17M -21.9M -87.4% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 25.1M +5.34M +27.1% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 19.7M 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2018 214M +562K +0.26% 01 Jan 2018 31 Dec 2018 10-K 15 Apr 2019
2017 213M +19.3M +9.97% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 194M +189M +3779% 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018
2015 5M +4.99M 01 Oct 2014 30 Sep 2015 10-K 27 Nov 2015
2014 11.1K* 01 Oct 2013 30 Sep 2014 10-K 27 Nov 2015
2011 9.74M +3.16M +47.9% 01 Oct 2010 30 Sep 2011 10-K/A 28 Dec 2011
2010 6.58M 01 Oct 2009 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.